SPY305.26-0.29 -0.09%
DIA255.94+0.67 0.26%
IXIC9,477.56-74.49 -0.78%

Aridis Pharmaceuticals Q1 EPS $(0.730) Up From $(0.990) YoY

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.730) per share. This is a 26.26 percent increase over losses of $(0.990) per share from the same period last year.

Benzinga · 05/12/2020 20:10

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.730) per share. This is a 26.26 percent increase over losses of $(0.990) per share from the same period last year.